Upgrade to SI Premium - Free Trial

Intellia Therapeutics (NTLA) PT Raised to $20 at BofA Securities

April 27, 2026 10:10 AM
BofA Securities analyst Alex Stranahan raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $20.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles